autologous t cells
Cell therapyexperimental
Clinical trial activity
12 trials · 19 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 1995 (NCT00001440)
Timeline
Indications
Studied for
- Anemia · Phase 2
- Breast Neoplasms · Phase 1
- Colorectal Neoplasms · Phase 1/Phase 2
- Cytomegalovirus Infections · Phase 1/Phase 2
- Fever · Phase 2
- Infections · Phase 2
- Leukemia, Lymphocytic, Chronic, B-Cell · Phase 2
- Leukemia, Prolymphocytic · Phase 2
- Lymphadenopathy · Phase 2
- Lymphocytosis · Phase 2
- Mesothelioma, Malignant · Phase 1
- Multiple Myeloma · Phase 2
- Neoplasm Metastasis · Phase 1
- Neoplasms · Phase 2
- Pancreatic Neoplasms · Phase 2
- Prostatic Neoplasms · Phase 1
- Sweat · Phase 2
- Thrombocytopenia · Phase 2
- Weight Loss · Phase 2
Mechanism of action
- T-lymphocytesSupplementation
T-lymphocytes supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- activated autologous t-cell
- activated t-cell
- activated t cells
- activated t lymphocyte
- autologous t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05908643 | Phase 1/Phase 2 (Phase 2) | Mar 15, 2023 | Clinical Trial Consultants AB, Karolinska Institute, Neogap Therapeutics, Region Västmanland |
| NCT05053295 | N/A | Jul 2, 2021 | Yonsei University |
| NCT04018261 | Phase 1/Phase 2 (Phase 2) | Jul 4, 2019 | Banc de Sang i Teixits, Universidad Autonoma de Barcelona, University of Valencia, Vall d'Hebron Institute of Research, Galatea Clinic |
| NCT03891706 | Phase 1 | Jan 8, 2019 | Guangzhou FineImmune Biotechnology Co., LTD., Sun Yat-Sen University |
| NCT05732948 | Phase 1 | Aug 2, 2018 | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd, Soochow University |
| NCT02530515 | Phase 2 | Dec 1, 2015 | University of Texas at Houston |
| NCT01802138 | N/A | Feb 1, 2013 | Seoul National University |
| NCT01355965 | Phase 1 | May 1, 2011 | University of Pennsylvania |
| NCT01245673 | Phase 2 | Apr 1, 2011 | University of Maryland, University of Pennsylvania |
| NCT00965718 | Phase 2 | Sep 1, 2009 | Green Cross Corporation, Yonsei University |
| NCT00837135 | Phase 1 | Jan 1, 2008 | University of Pennsylvania |
| NCT00001440 | Phase 1 | Jul 1, 1995 | National Cancer Institute (NCI) |
Showing 12 of 12 trials
Page 1 / 1
Organizations
Research & Development (19)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Pennsylvania | Academic/Hospital | 3 | 3 | 2 | 2008 |
| Yonsei University | Academic/Hospital | 2 | 1 | 2 | 2009 |
| Banc de Sang i Teixits | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Clinical Trial Consultants AB | For profit | 1 | 0 | 1 | 2023 |
| Green Cross Corporation | For profit | 1 | 1 | 1 | 2009 |
| Guangzhou FineImmune Biotechnology Co., LTD. | Government | 1 | 1 | 1 | 2019 |
| Karolinska Institute | Academic/Hospital | 1 | 0 | 1 | 2023 |
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 1995 |
| Neogap Therapeutics | For profit | 1 | 1 | 1 | 2023 |
| Region Västmanland | Government | 1 | 0 | 1 | 2023 |
| Seoul National University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | For profit | 1 | 1 | 1 | 2018 |
| Soochow University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Universidad Autonoma de Barcelona | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of Maryland | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of Valencia | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Vall d'Hebron Institute of Research, Galatea Clinic | Academic/Hospital | 1 | 0 | 1 | 2019 |
19 organizations
Page 1 / 1